[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Tretinoin.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Tretinoin.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Tretinoin.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Tretinoin.]
[L04AA27, fingolimod, Tretinoin may increase the immunosuppressive activities of Fingolimod.]
[J01EC02, sulfadiazine, The metabolism of Tretinoin can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Tretinoin can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Tretinoin.]
[J01EC03, sulfamoxole, The metabolism of Tretinoin can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Tretinoin can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Tretinoin can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Tretinoin can be decreased when combined with Sulfisoxazole.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Tretinoin.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Mercaptopurine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Tretinoin.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Tretinoin.]
[G03BA03, testosterone, The metabolism of Tretinoin can be decreased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Tetracaine.]
[S03AA02, tetracycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Tetracycline.]
[A04AD10, dronabinol, The metabolism of Tretinoin can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Tretinoin can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Tretinoin can be decreased when combined with Theophylline.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Eribulin.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Tretinoin is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Tretinoin.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Tretinoin.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Thioridazine is combined with Tretinoin.]
[B02AB01, aprotinin, The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aprotinin.]
[B01AC05, ticlopidine, The metabolism of Tretinoin can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Tretinoin.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Tretinoin.]
[M02AX02, tolazoline, The risk or severity of adverse effects can be increased when Tretinoin is combined with Tolazoline.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Tretinoin.]
[N02AX02, tramadol, The metabolism of Tretinoin can be decreased when combined with Tramadol.]
[B02AA02, tranexamic acid, The risk or severity of hypercoagulability can be increased when Tretinoin is combined with Tranexamic acid.]
[N06AF04, tranylcypromine, The metabolism of Tretinoin can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The metabolism of Tretinoin can be decreased when combined with Trazodone.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Antilymphocyte immunoglobulin (horse).]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Tretinoin.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Tretinoin.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Tretinoin.]
[C03AA06, trichlormethiazide, Tretinoin may increase the hypotensive activities of Trichlormethiazide.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Tretinoin.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Tretinoin can be decreased when combined with Trimethadione.]
[C02BA01, trimethaphan, Tretinoin may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The metabolism of Tretinoin can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Tretinoin can be decreased when combined with Trimipramine.]
[D05BA01, trioxsalen, The risk or severity of adverse effects can be increased when Tretinoin is combined with Trioxsalen.]
[J01FA08, troleandomycin, The metabolism of Tretinoin can be decreased when combined with Troleandomycin.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Tretinoin is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Tretinoin.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Belimumab.]
[L02BX03, abiraterone, The metabolism of Tretinoin can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Tretinoin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Tretinoin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Tretinoin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Tretinoin can be decreased when combined with Rilpivirine.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Tretinoin is combined with Belatacept.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Tretinoin.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Tretinoin.]
[C08DA01, verapamil, The metabolism of Tretinoin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Tretinoin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Tretinoin.]
[C04AX07, vincamine, Tretinoin may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Tretinoin.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Tretinoin.]
[S01XA02, vitamin A, The risk or severity of adverse effects can be increased when Vitamin A is combined with Tretinoin.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Tretinoin.]
[S01AA13, fusidic acid, The metabolism of Tretinoin can be decreased when combined with Fusidic acid.]
[C03BA10, xipamide, Tretinoin may increase the hypotensive activities of Xipamide.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Tretinoin.]
[J05AE02, indinavir, The metabolism of Tretinoin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Tretinoin.]
[R03DC01, zafirlukast, The metabolism of Tretinoin can be decreased when combined with Zafirlukast.]
[L01XD05, temoporfin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Temoporfin.]
[N05AE04, ziprasidone, The metabolism of Tretinoin can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The therapeutic efficacy of Drospirenone can be decreased when used in combination with Tretinoin.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Tretinoin.]
[S01LA01, verteporfin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Verteporfin.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Tretinoin.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ruxolitinib.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Tretinoin.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Tretinoin.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tretinoin.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Tretinoin.]
[J02AC03, voriconazole, The metabolism of Tretinoin can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Tretinoin.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Tretinoin.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Tretinoin.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Tretinoin is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Tretinoin.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tretinoin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Tretinoin.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Tretinoin.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tretinoin.]
[L01FD02, pertuzumab, The risk or severity of cardiotoxicity can be increased when Tretinoin is combined with Pertuzumab.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Tretinoin.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Tretinoin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Tretinoin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Tretinoin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Teriflunomide.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Tretinoin is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Tretinoin can be decreased when combined with Regorafenib.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Tretinoin.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may decrease the cardiotoxic activities of Tretinoin.]
[J05AE04, nelfinavir, The metabolism of Tretinoin can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Bendamustine.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Tretinoin.]
[C08CA13, lercanidipine, The risk or severity of adverse effects can be increased when Lercanidipine is combined with Tretinoin.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Tretinoin.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Tretinoin.]
[L04AA29, tofacitinib, Tretinoin may increase the immunosuppressive activities of Tofacitinib.]
[L01EX07, cabozantinib, The metabolism of Tretinoin can be decreased when combined with Cabozantinib.]
[G04BE03, sildenafil, The metabolism of Tretinoin can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Tretinoin.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Tretinoin.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Tretinoin.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Tretinoin.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dimethyl fumarate.]
[M04AB03, benzbromarone, The metabolism of Tretinoin can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Tretinoin can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Tretinoin can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Tretinoin is combined with Everolimus.]
[L01EC02, dabrafenib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dabrafenib.]
[L01EE01, trametinib, The metabolism of Tretinoin can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Benzyl alcohol.]
[V04CX06, hexyl 5-aminolevulinate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hexaminolevulinate.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Tretinoin.]
[C08EA02, bepridil, The risk or severity of adverse effects can be increased when Tretinoin is combined with Bepridil.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Tretinoin.]
[C02KX04, macitentan, Tretinoin may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Tretinoin.]
[J05AP05, simeprevir, The metabolism of Tretinoin can be decreased when combined with Simeprevir.]
[B02AA03, 4-aminomethylbenzoic acid, The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aminomethylbenzoic acid.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Tretinoin.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Acebutolol.]
[A16AA07, metreleptin, The metabolism of Tretinoin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Tretinoin can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Tretinoin.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Tretinoin.]
[V03AB34, fomepizole, The metabolism of Tretinoin can be decreased when combined with Fomepizole.]
[C02CC01, bethanidine, Tretinoin may increase the hypotensive activities of Bethanidine.]
[C10AB02, bezafibrate, The metabolism of Tretinoin can be decreased when combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Tretinoin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Tretinoin can be decreased when combined with Ceritinib.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Tretinoin.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Tretinoin is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Idelalisib.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Empagliflozin.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Tretinoin.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Tretinoin is combined with Peginterferon beta-1a.]
[J01XA05, oritavancin, The metabolism of Tretinoin can be decreased when combined with Oritavancin.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Decitabine.]
[D05BA03, 5-methoxypsoralen, The risk or severity of adverse effects can be increased when Tretinoin is combined with Bergapten.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pirfenidone.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Tretinoin.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Tretinoin.]
[B01AA01, dicumarol, The metabolism of Tretinoin can be decreased when combined with Dicoumarol.]
[L04AC10, secukinumab, The metabolism of Tretinoin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Palbociclib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Tretinoin is combined with Panobinostat.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Tretinoin.]
[N02BE01, acetaminophen, The metabolism of Tretinoin can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Tretinoin.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Tretinoin.]
[A02BC03, lansoprazole, The metabolism of Tretinoin can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Trabectedin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Tretinoin can be decreased when combined with Isavuconazole.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Tretinoin.]
[A10BB31, acetohexamide, The metabolism of Tretinoin can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Tretinoin.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Tretinoin.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Tretinoin.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Tretinoin can be decreased when combined with Venetoclax.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Bromocriptine.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be decreased when combined with Tretinoin.]
[C08CA01, amlodipine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Tretinoin.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Bupivacaine.]
[C07AA19, bupranolol, Tretinoin may increase the hypotensive activities of Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Tretinoin.]
[N05BE01, buspirone, The metabolism of Tretinoin can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Tretinoin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Tretinoin.]
[L01XK03, rucaparib, The metabolism of Tretinoin can be decreased when combined with Rucaparib.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Tretinoin can be decreased when combined with Ribociclib.]
[L04AA36, ocrelizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ocrelizumab.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Tretinoin.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Tretinoin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Oxybuprocaine.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Tretinoin.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Tretinoin.]
[J05AE09, tipranavir, The metabolism of Tretinoin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Tretinoin.]
[L04AB02, infliximab, The metabolism of Tretinoin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Tretinoin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Tretinoin.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Tretinoin.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Tretinoin can be increased when combined with Delafloxacin.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Tretinoin.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Tretinoin is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Tretinoin.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Tretinoin.]
[J05AG03, efavirenz, The metabolism of Tretinoin can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Tretinoin.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Tretinoin.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Nesiritide.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Tretinoin can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Tretinoin can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Acetyldigoxin may decrease the cardiotoxic activities of Tretinoin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Capsaicin.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Tretinoin is combined with Captopril.]
[L02BB05, apalutamide, The metabolism of Tretinoin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Tretinoin.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Tretinoin.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Tretinoin.]
[N03AX24, cannabidiol, The metabolism of Tretinoin can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Tretinoin can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Baricitinib.]
[C07AB08, celiprolol, Tretinoin may increase the hypotensive activities of Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Tretinoin.]
[L01XX62, ivosidenib, The metabolism of Tretinoin can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Tretinoin can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Tretinoin can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Tretinoin.]
[J01AA13, eravacycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Eravacycline.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Tretinoin.]
[J01AA14, sarecycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Sarecycline.]
[J01AA15, omadacycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Omadacycline.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Tretinoin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Tretinoin.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Tretinoin.]
[L04AA39, emapalumab, The metabolism of Tretinoin can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Tretinoin.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Tretinoin.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ravulizumab.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Tretinoin is combined with Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Tretinoin.]
[P02BX04, triclabendazole, The metabolism of Tretinoin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Tretinoin.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Tretinoin is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Tretinoin can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Tretinoin.]
[N05BA09, clobazam, The metabolism of Tretinoin can be decreased when combined with Clobazam.]
[J01AA11, clomocycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Clomocycline.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Tretinoin can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Tretinoin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Risankizumab.]
[L01EM03, alpelisib, The serum concentration of Tretinoin can be decreased when it is combined with Alpelisib.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Cyamemazine.]
[C03BX03, cicletanine, Tretinoin may increase the hypotensive activities of Cicletanine.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Upadacitinib.]
[N07XX11, pitolisant, The serum concentration of Tretinoin can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Tretinoin.]
[C03AA09, cyclothiazide, Tretinoin may increase the hypotensive activities of Cyclothiazide.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Tretinoin is combined with Deflazacort.]
[G03DB05, demegestone, The therapeutic efficacy of Demegestone can be decreased when used in combination with Tretinoin.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Tretinoin.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Tretinoin.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Tretinoin.]
[G03AC09, desogestrel, The therapeutic efficacy of Desogestrel can be decreased when used in combination with Tretinoin.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Tretinoin.]
[N03AX25, cenobamate, The serum concentration of Tretinoin can be decreased when it is combined with Cenobamate.]
[L01EX18, avapritinib, The metabolism of Tretinoin can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Tretinoin can be decreased when it is combined with Lemborexant.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Teprotumumab.]
[M01AX21, diacetylrhein, The metabolism of Tretinoin can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Osilodrostat can be decreased when combined with Tretinoin.]
[J05AE05, amprenavir, The metabolism of Tretinoin can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Tretinoin.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Tretinoin.]
[G03DB08, dienogest, The therapeutic efficacy of Dienogest can be decreased when used in combination with Tretinoin.]
[L01XD01, porfimer sodium, The risk or severity of adverse effects can be increased when Tretinoin is combined with Porfimer sodium.]
[N02CC06, eletriptan, The metabolism of Tretinoin can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Tretinoin can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Tretinoin.]
[C08CA16, clevidipine, The metabolism of Tretinoin can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Tretinoin.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Tretinoin.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Tretinoin.]
[C02AA06, methoserpidine, Tretinoin may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Tretinoin.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Opicapone.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluprednidene.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Tretinoin.]
[L01EX22, selpercatinib, The serum concentration of Tretinoin can be increased when it is combined with Selpercatinib.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Tretinoin.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Tretinoin is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Stepronin.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Tretinoin.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Tretinoin.]
[L04AC19, satralizumab, The serum concentration of Tretinoin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The metabolism of Tretinoin can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Tretinoin can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Tretinoin.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Tretinoin.]
[A10BB02, chlorpropamide, The metabolism of Tretinoin can be decreased when combined with Chlorpropamide.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Tretinoin.]
[M03BB03, chlorzoxazone, The metabolism of Tretinoin can be decreased when combined with Chlorzoxazone.]
[M01AB08, etodolac, The metabolism of Tretinoin can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The metabolism of Tretinoin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Tretinoin can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fludarabine.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Tretinoin.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Tretinoin can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Tretinoin is combined with Vericiguat.]
[L01EX21, tepotinib, The metabolism of Tretinoin can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Tretinoin can be decreased when combined with Felbamate.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fenoldopam.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Tretinoin.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Tretinoin.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Tretinoin.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Tretinoin.]
[A16AX19, fosdenopterin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fosdenopterin.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ponesimod.]
[S01LA08, bevacizumab, The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Tretinoin.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tretinoin.]
[H04AA02, dasiglucagon, Tretinoin may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Tretinoin can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Tretinoin can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Tretinoin can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Tretinoin can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Tretinoin.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pegcetacoplan.]
[C03DA05, finerenone, The metabolism of Finerenone can be decreased when combined with Tretinoin.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Tretinoin is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Tretinoin.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Anifrolumab.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Tretinoin.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Tretinoin.]
[A10BB12, glimepiride, The metabolism of Tretinoin can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Tretinoin.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Tretinoin.]
[N06AX25, St. John's wort extract, The metabolism of Tretinoin can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Tretinoin can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Tretinoin.]
[J04BA01, clofazimine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Tretinoin can be decreased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Tretinoin can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Levobupivacaine.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Clomipramine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Tretinoin.]
[C01EB24, mavacamten, The serum concentration of Tretinoin can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Tretinoin.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Deucravacitinib.]
[H01CC04, linzagolix, The serum concentration of Tretinoin can be increased when it is combined with Linzagolix.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Tretinoin.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Tretinoin.]
[N05AH02, clozapine, The metabolism of Tretinoin can be decreased when combined with Clozapine.]
[H01AC08, somatrogon, The metabolism of Tretinoin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Cocaine.]
[M09AX11, palovarotene, The risk or severity of adverse effects can be increased when Tretinoin is combined with Palovarotene.]
[C02KB01, metyrosine, Tretinoin may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Tretinoin can be increased when combined with Bimekizumab.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Tretinoin is combined with Desflurane.]
[A10BX03, nateglinide, The metabolism of Tretinoin can be decreased when combined with Nateglinide.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Tretinoin can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ciclesonide.]
[M01AH03, valdecoxib, The metabolism of Tretinoin can be decreased when combined with Valdecoxib.]
[C01AA06, lanatoside C, Lanatoside C may decrease the cardiotoxic activities of Tretinoin.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Tretinoin.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Tretinoin.]
[J02AC02, itraconazole, The metabolism of Tretinoin can be decreased when combined with Itraconazole.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Tretinoin.]
[J02AC04, posaconazole, The metabolism of Tretinoin can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, Tretinoin may increase the hypotensive activities of Lacidipine.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Tretinoin.]
[S01BA03, cortisone, The metabolism of Tretinoin can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Lofexidine.]
[R06AX13, loratadine, The metabolism of Tretinoin can be decreased when combined with Loratadine.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Lisinopril is combined with Tretinoin.]
[C08CA11, manidipine, The metabolism of Tretinoin can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Meprednisone.]
[R06AE03, cyclizine, The metabolism of Tretinoin can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Eplerenone is combined with Tretinoin.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Tretinoin.]
[C03AA07, cyclopenthiazide, Tretinoin may increase the hypotensive activities of Cyclopenthiazide.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Tretinoin.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Tretinoin.]
[S01XA18, cyclosporine, Tretinoin may increase the immunosuppressive activities of Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Tretinoin.]
[N06BA07, modafinil, The metabolism of Tretinoin can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Cyproheptadine.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Moexipril is combined with Tretinoin.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Tretinoin.]
[C03XA02, conivaptan, The metabolism of Tretinoin can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Moxonidine.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Cytarabine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Tretinoin.]
[M01AH05, etoricoxib, The metabolism of Tretinoin can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dactinomycin.]
[G03XA01, danazol, The metabolism of Tretinoin can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Tretinoin can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Tretinoin.]
[C02CC04, debrisoquin, Tretinoin may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Tretinoin.]
[M01AX01, nabumetone, The metabolism of Tretinoin can be decreased when combined with Nabumetone.]
[J01AA01, demeclocycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Demeclocycline.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Nebivolol.]
[N06AX06, nefazodone, The metabolism of Tretinoin can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Tretinoin.]
[L02BB02, nilutamide, The metabolism of Tretinoin can be decreased when combined with Nilutamide.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tretinoin.]
[N06AA01, desipramine, The metabolism of Tretinoin can be decreased when combined with Desipramine.]
[C01AA07, deslanoside, Deslanoside may decrease the cardiotoxic activities of Tretinoin.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Tretinoin.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Tretinoin is combined with Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Tretinoin.]
[N03AF02, oxcarbazepine, The metabolism of Tretinoin can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Tretinoin can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Tretinoin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Tretinoin can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The metabolism of Tretinoin can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Tretinoin can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Tretinoin can be decreased when combined with Paramethadione.]
[N06AB05, paroxetine, The metabolism of Tretinoin can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Tretinoin can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Tretinoin.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Diazoxide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Diclofenamide.]
[S01BC03, diclofenac, The metabolism of Tretinoin can be decreased when combined with Diclofenac.]
[L01XD03, methyl 5-aminolevulinate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Methyl aminolevulinate.]
[C02DG01, pinacidil, Tretinoin may increase the hypotensive activities of Pinacidil.]
[A10BG03, pioglitazone, The metabolism of Tretinoin can be decreased when combined with Pioglitazone.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pipamperone.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Tretinoin.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pirarubicin.]
[L02AA01, diethylstilbestrol, The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Tretinoin.]
[C08CA03, isradipine, The metabolism of Tretinoin can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Difluocortolone.]
[C01AA04, digitoxin, Digitoxin may decrease the cardiotoxic activities of Tretinoin.]
[C01AA05, digoxin, Digoxin may decrease the cardiotoxic activities of Tretinoin.]
[C02DB01, dihydralazine, Tretinoin may increase the hypotensive activities of Dihydralazine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Tretinoin.]
[N02AA03, hydromorphone, The metabolism of Tretinoin can be decreased when combined with Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Tretinoin.]
[J05AE08, atazanavir, The metabolism of Tretinoin can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Tretinoin can be decreased when combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Tretinoin can be decreased when combined with Diltiazem.]
[C05CA03, diosmin, The metabolism of Tretinoin can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Tretinoin can be decreased when combined with Quazepam.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Tretinoin is combined with Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dipyridamole.]
[A03FA02, cisapride, The metabolism of Tretinoin can be decreased when combined with Cisapride.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Tretinoin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Tretinoin.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Natalizumab.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Tretinoin.]
[S02AA12, rifamycin SV, The metabolism of Tretinoin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Tretinoin can be increased when combined with Rifapentine.]
[N05AX08, risperidone, Tretinoin may increase the hypotensive activities of Risperidone.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Tretinoin.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Tretinoin.]
[A04AD12, aprepitant, The metabolism of Tretinoin can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Tretinoin.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Tretinoin.]
[S01BC05, ketorolac, The metabolism of Tretinoin can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Tretinoin.]
[R03AC12, salmeterol, The metabolism of Tretinoin can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Tretinoin.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Tretinoin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Tretinoin.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Doxorubicin.]
[J01AA02, doxycycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Doxycycline.]
[N06AB06, sertraline, The metabolism of Tretinoin can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Tretinoin.]
[C10AA01, simvastatin, The metabolism of Tretinoin can be decreased when combined with Simvastatin.]
[C09AA11, spirapril, Tretinoin may increase the hypotensive activities of Spirapril.]
[C07AB13, talinolol, Tretinoin may increase the hypotensive activities of Talinolol.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Corticotropin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Temozolomide.]
[M01AC02, tenoxicam, The metabolism of Tretinoin can be decreased when combined with Tenoxicam.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Terazosin.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Tretinoin.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Tretinoin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Tretinoin.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Tretinoin.]
[C03CA04, torsemide, The metabolism of Tretinoin can be decreased when combined with Torasemide.]
[J01AA12, tigecycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Tigecycline.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Tretinoin.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Tretinoin is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Trofosfamide.]
[C02CA06, urapidil, Tretinoin may increase the hypotensive activities of Urapidil.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Tretinoin.]
[S01GX10, epinastine, The metabolism of Tretinoin can be decreased when combined with Epinastine.]
[C08CA12, mepirodipine, The metabolism of Tretinoin can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Tretinoin can be decreased when combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Tretinoin.]
[C09AA15, zofenopril, Tretinoin may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Tretinoin can be decreased when combined with Zolpidem.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Tretinoin.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Tretinoin.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Carboplatin.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Guanfacine.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Tretinoin is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Tretinoin can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, Valproic acid may increase the Pseudotumor Cerebri activities of Tretinoin.]
[S01AA17, erythromycin, The metabolism of Tretinoin can be decreased when combined with Erythromycin.]
[G03CA03, estradiol, The therapeutic efficacy of Estradiol can be decreased when used in combination with Tretinoin.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Estramustine.]
[J04AK02, ethambutol, The metabolism of Tretinoin can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Tretinoin can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Tretinoin.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Amifostine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Tretinoin.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Tretinoin.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Tretinoin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Tretinoin.]
[R06AX12, terfenadine, The metabolism of Tretinoin can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Tretinoin.]
[N06AB08, fluvoxamine, The metabolism of Tretinoin can be decreased when combined with Fluvoxamine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Tretinoin.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Tretinoin.]
[C08CA02, felodipine, The metabolism of Tretinoin can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The metabolism of Tretinoin can be decreased when combined with Fenfluramine.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Tretinoin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tretinoin.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Tretinoin.]
[C01BC04, flecainide, The metabolism of Tretinoin can be decreased when combined with Flecainide.]
[J02AC01, fluconazole, The metabolism of Tretinoin can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Tretinoin.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Tretinoin.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Tretinoin.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Tretinoin.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Tretinoin.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Tretinoin.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Tretinoin.]
[N06AB03, fluoxetine, The metabolism of Tretinoin can be decreased when combined with Fluoxetine.]
[N05CD01, flurazepam, The metabolism of Tretinoin can be decreased when combined with Flurazepam.]
[S01BC04, flurbiprofen, The metabolism of Tretinoin can be decreased when combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Tretinoin can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Tretinoin.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Tretinoin.]
[J05AE10, darunavir, The metabolism of Tretinoin can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Tretinoin.]
[N05CF04, eszopiclone, The metabolism of Tretinoin can be decreased when combined with Eszopiclone.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Tretinoin.]
[C10AB04, gemfibrozil, The metabolism of Tretinoin can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Tretinoin.]
[J05AG04, etravirine, The metabolism of Tretinoin can be decreased when combined with Etravirine.]
[G03XA02, gestrinone, The therapeutic efficacy of Gestrinone can be decreased when used in combination with Tretinoin.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Tretinoin.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Tretinoin.]
[A10BB01, glyburide, The metabolism of Tretinoin can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Tretinoin.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Tretinoin.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Tretinoin.]
[C05AE01, nitroglycerin, The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Tretinoin.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Tretinoin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Tretinoin.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Tretinoin.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Tretinoin.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Tretinoin.]
[S01EX01, guanethidine, Tretinoin may increase the hypotensive activities of Guanethidine.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Tretinoin.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Tretinoin.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Tretinoin.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Quetiapine.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Irinotecan.]
[C09CA01, losartan, The metabolism of Tretinoin can be decreased when combined with Losartan.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Tretinoin.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Tretinoin.]
[B02AB02, alpha 1-antitrypsin, The risk or severity of Thrombosis can be increased when Tretinoin is combined with Alpha-1-proteinase inhibitor.]
[J05AG01, nevirapine, The metabolism of Tretinoin can be increased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Tretinoin can be decreased when combined with Nilvadipine.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Tretinoin is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Tretinoin.]
[S02BA01, hydrocortisone, The metabolism of Tretinoin can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydroflumethiazide.]
[S02AA06, hydrogen peroxide, The risk or severity of Thrombosis can be increased when Tretinoin is combined with Hydrogen peroxide.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydroxychloroquine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The metabolism of Tretinoin can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Tretinoin can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, Tretinoin may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Tretinoin.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Tretinoin.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Tretinoin.]
[N06AA02, imipramine, The metabolism of Tretinoin can be decreased when combined with Imipramine.]
[L01CD03, paclitaxel poliglumex, The risk or severity of cardiotoxicity can be increased when Tretinoin is combined with Paclitaxel poliglumex.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Tretinoin.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Tixocortol.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Tretinoin.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Topotecan.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Tretinoin is combined with Indapamide.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Tretinoin.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Indoramin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Tretinoin.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Tretinoin.]
[N06AX17, milnacipran, The metabolism of Tretinoin can be decreased when combined with Milnacipran.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Tretinoin.]
[N05BA12, alprazolam, The metabolism of Tretinoin can be decreased when combined with Alprazolam.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Tretinoin.]
[C10AA06, cerivastatin, The metabolism of Tretinoin can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, Tretinoin may increase the hypotensive activities of Alprenolol.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Tretinoin.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Tretinoin.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Tretinoin.]
[P01AX06, atovaquone, The metabolism of Tretinoin can be decreased when combined with Atovaquone.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Tretinoin is combined with Imidapril.]
[N01AB06, isoflurane, The metabolism of Tretinoin can be decreased when combined with Isoflurane.]
[J04AC01, isoniazid, The metabolism of Tretinoin can be decreased when combined with Isoniazid.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Isosorbide dinitrate.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Isoxsuprine.]
[L04AC07, tocilizumab, The metabolism of Tretinoin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Tretinoin.]
[C02KD01, ketanserin, Tretinoin may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Tretinoin.]
[H02CA04, levoketoconazole, The metabolism of Tretinoin can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Tretinoin can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Tretinoin.]
[M02AA10, ketoprofen, The metabolism of Tretinoin can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Tretinoin can be decreased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Tretinoin can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Rotigotine.]
[M01AE11, tiaprofenic acid, The risk or severity of adverse effects can be increased when Tretinoin is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Labetalol is combined with Tretinoin.]
[C02AA05, deserpidine, Tretinoin may increase the hypotensive activities of Deserpidine.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Tretinoin.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Tretinoin is combined with Etacrynic acid.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Tretinoin.]
[G03AD01, levonorgestrel, The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Tretinoin.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Tretinoin is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Tretinoin can be increased when combined with Armodafinil.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Tretinoin.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Tretinoin.]
[C10AA02, lovastatin, The metabolism of Tretinoin can be decreased when combined with Lovastatin.]
[J01AA04, lymecycline, The risk or severity of pseudotumor cerebri can be increased when Lymecycline is combined with Tretinoin.]
[G03DC03, lynestrenol, The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Tretinoin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Tretinoin.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Tretinoin is combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Tretinoin.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Tretinoin.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Mechlorethamine.]
[C01AA08, medigoxin, Metildigoxin may decrease the cardiotoxic activities of Tretinoin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Melphalan.]
[N06DX01, memantine, The metabolism of Tretinoin can be decreased when combined with Memantine.]
[B02BA02, vitamin K3, The risk or severity of Thrombosis can be increased when Tretinoin is combined with Menadione.]
[N02AB02, meperidine, The metabolism of Tretinoin can be decreased when combined with Meperidine.]
[N03AB04, mephenytoin, The metabolism of Tretinoin can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Tretinoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Mepivacaine.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Tretinoin.]
[J01AA05, methacycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Metacycline.]
[N07BC02, methadone, The metabolism of Tretinoin can be decreased when combined with Methadone.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Tretinoin.]
[L01XD04, aminolevulinic acid, The risk or severity of adverse effects can be increased when Tretinoin is combined with Aminolevulinic acid.]
[H03BB02, methimazole, The metabolism of Tretinoin can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Tretinoin.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Tretinoin.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Tretinoin.]
[N05AA02, methotrimeprazine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Methotrimeprazine.]
[D05BA02, methoxsalen, The risk or severity of adverse effects can be increased when Tretinoin is combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Tretinoin.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Tretinoin.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Tretinoin is combined with Methyldopa.]
[V04CG05, methylene blue, The risk or severity of adverse effects can be increased when Tretinoin is combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Methylprednisolone.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Tretinoin.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Tretinoin.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Tretinoin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Tretinoin can be decreased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Tretinoin can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Tretinoin.]
[S02AA13, miconazole, The metabolism of Tretinoin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Tretinoin.]
[N05CD08, midazolam, The metabolism of Tretinoin can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The serum concentration of Tretinoin can be increased when it is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Tretinoin can be decreased when combined with Valsartan.]
[J01AA08, minocycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Minocycline.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Tretinoin.]
[L01XX23, mitotane, The metabolism of Tretinoin can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tretinoin.]
[C01BD01, amiodarone, The metabolism of Tretinoin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Tretinoin can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Tretinoin can be decreased when combined with Morphine.]
[L04AB05, certolizumab pegol, The metabolism of Tretinoin can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Tretinoin can be decreased when combined with Eltrombopag.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Tretinoin.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Tretinoin is combined with Mycophenolic acid.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Tretinoin.]
[P01BA06, amodiaquine, The metabolism of Tretinoin can be decreased when combined with Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Tretinoin can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Tretinoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Tretinoin.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Nadolol.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Tretinoin.]
[V03AB15, naloxone, The metabolism of Tretinoin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Tretinoin can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Tretinoin can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Tretinoin.]
[A10BG01, troglitazone, The metabolism of Tretinoin can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Tretinoin is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Tretinoin.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Tretinoin.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Tretinoin.]
[L02BG04, letrozole, The metabolism of Tretinoin can be decreased when combined with Letrozole.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Tretinoin is combined with Remifentanil.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Tretinoin.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Levosimendan.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Tretinoin.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tretinoin.]
[N06AX23, desvenlafaxine, The metabolism of Tretinoin can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Telmisartan.]
[M04AA03, febuxostat, The risk or severity of adverse effects can be increased when Tretinoin is combined with Febuxostat.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Tretinoin.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Tretinoin.]
[C08CA04, nicardipine, The metabolism of Tretinoin can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Tretinoin.]
[N07BA01, nicotine, The metabolism of Tretinoin can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Tretinoin.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Tretinoin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of adverse effects can be increased when Nimodipine is combined with Tretinoin.]
[C08CA07, nisoldipine, The risk or severity of adverse effects can be increased when Nisoldipine is combined with Tretinoin.]
[C08CA08, nitrendipine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Tretinoin.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Tretinoin.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Tretinoin.]
[C02DD01, nitroprusside, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Tretinoin.]
[G03DC02, norethindrone, The therapeutic efficacy of Norethisterone can be decreased when used in combination with Tretinoin.]
[G03AC07, norgestrienone, The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Tretinoin.]
[C02KX01, bosentan, The metabolism of Tretinoin can be increased when combined with Bosentan.]
[R05DA07, noscapine, The metabolism of Tretinoin can be decreased when combined with Noscapine.]
[L04AC04, rilonacept, The metabolism of Tretinoin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Tretinoin can be decreased when combined with Omeprazole.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Tretinoin.]
[C01AC01, ouabain, Ouabain may decrease the cardiotoxic activities of Tretinoin.]
[A14AA08, oxandrolone, The metabolism of Tretinoin can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Tretinoin can be decreased when combined with Oxycodone.]
[S01AA04, oxytetracycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Oxytetracycline.]
[G03DB06, chlormadinone, The therapeutic efficacy of Chlormadinone can be decreased when used in combination with Tretinoin.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Papaverine.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Tretinoin.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Penbutolol.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Penicillamine.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Tretinoin.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Tretinoin.]
[N05CA01, pentobarbital, The metabolism of Tretinoin can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Tretinoin.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Tretinoin.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Tretinoin.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Tretinoin.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Tretinoin.]
[N03AA02, phenobarbital, The metabolism of Tretinoin can be increased when combined with Phenobarbital.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Phenoxybenzamine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Tretinoin.]
[V03AB36, phentolamine, The risk or severity of adverse effects can be increased when Phentolamine is combined with Tretinoin.]
[M02AA01, phenylbutazone, The metabolism of Tretinoin can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Tretinoin.]
[L04AB06, golimumab, The metabolism of Tretinoin can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Levofloxacin.]
[C08CX01, mibefradil, The metabolism of Tretinoin can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Tretinoin can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Tretinoin.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Tretinoin.]
[J05AE01, saquinavir, The metabolism of Tretinoin can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Tretinoin is combined with Eprosartan.]
[S01BC06, piroxicam, The metabolism of Tretinoin can be decreased when combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Tretinoin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Tretinoin can be decreased when combined with Irbesartan.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Tretinoin.]
[A10BG02, rosiglitazone, The metabolism of Tretinoin can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The risk or severity of cardiotoxicity can be increased when Tretinoin is combined with Anastrozole.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Tretinoin.]
[L04AC08, canakinumab, The metabolism of Tretinoin can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Tretinoin may increase the hypotensive activities of Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Tretinoin can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Tretinoin.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Tretinoin.]
[C07AB01, practolol, Tretinoin may increase the hypotensive activities of Practolol.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Tretinoin.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Tretinoin.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Tretinoin is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Tretinoin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Tretinoin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Tretinoin can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Tretinoin can be increased when combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Tretinoin can be decreased when combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Tretinoin can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Tretinoin can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Tretinoin.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Tretinoin.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Tretinoin.]
[C07AA05, propranolol, The risk or severity of adverse effects can be increased when Propranolol is combined with Tretinoin.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Tretinoin.]
[C01AB01, proscillaridin, Proscillaridin may decrease the cardiotoxic activities of Tretinoin.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Tretinoin is combined with Epoprostenol.]
[R03DC03, montelukast, The metabolism of Tretinoin can be decreased when combined with Montelukast.]
[N05AX12, aripiprazole, Aripiprazole may increase the hypotensive activities of Tretinoin.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Tretinoin.]
[P01BD01, pyrimethamine, The metabolism of Tretinoin can be decreased when combined with Pyrimethamine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Tretinoin.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Tretinoin.]
[P01BC01, quinine, The metabolism of Tretinoin can be decreased when combined with Quinine.]
[C02AA01, rescinnamine, Tretinoin may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The metabolism of Tretinoin can be increased when combined with Reserpine.]
[S01XA26, riboflavin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Riboflavin.]
[J04AB02, rifampin, The metabolism of Tretinoin can be increased when combined with Rifampicin.]
[J01AA09, rolitetracycline, The risk or severity of pseudotumor cerebri can be increased when Tretinoin is combined with Rolitetracycline.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Tretinoin is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Tretinoin.]
[N05CA06, secobarbital, The metabolism of Tretinoin can be increased when combined with Secobarbital.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Tretinoin.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Tretinoin is combined with Obinutuzumab.]
[B02AA01, 6-aminocaproic acid, The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aminocaproic acid.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Tretinoin.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Tretinoin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Tretinoin.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Tretinoin.]
[C03DA01, spironolactone, The metabolism of Tretinoin can be decreased when combined with Spironolactone.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Tretinoin is combined with Hydrocortisone butyrate.]
